(Total Views: 469)
Posted On: 03/08/2021 5:49:30 PM
Post# of 153898
Liked hearing potential sales in Philippines and for US prices no less. Cancer data sounded promising and we just need some MRIs to finish out what is needed to present a BTD to FDA.
I know NP said HIV hopefully revenue by end of the year, but I'm not buying that. First they still can't give a timeline because the receptor occupancy is messed up and it appears they don't have their head wrapped around how long it will take to fix. To even have a chance of hitting December approval this needs to be filed in April. The FDA takes 60 days just to accept(2 months if you're keeping track at home), and 6 months MINIMUM to review IF they accept our data..which they graciously offered to look over in a 30 day window so there's another month because I can guarantee the FDA will take the full time allotted.
The only way we see hiv revenue/approval is if we get full covid approval (not just EUA) and can do a label expansion for HIV.
Still an informative call, disappointed our results for COVID didn't hit home runs every where...but the most disappointing was people who ask the same dang question every stinking conference call. Let me help you out.
NO THE COVID VARIANTS DON'T MATTER... WE ARE AN IMMUNOMODULATORY DRUG NOT AN ANTIVIRAL...had you done any due diligence before dropping money on this and then watched any Dr been presentation or listened to the last 300 conference calls you would know this..
Almost forgot...I thought their take on potential suitors was interesting and that NP and SK are on their way to see a wealthy individual in los Angeles about a possible trial. Ok I'm done now.
I know NP said HIV hopefully revenue by end of the year, but I'm not buying that. First they still can't give a timeline because the receptor occupancy is messed up and it appears they don't have their head wrapped around how long it will take to fix. To even have a chance of hitting December approval this needs to be filed in April. The FDA takes 60 days just to accept(2 months if you're keeping track at home), and 6 months MINIMUM to review IF they accept our data..which they graciously offered to look over in a 30 day window so there's another month because I can guarantee the FDA will take the full time allotted.
The only way we see hiv revenue/approval is if we get full covid approval (not just EUA) and can do a label expansion for HIV.
Still an informative call, disappointed our results for COVID didn't hit home runs every where...but the most disappointing was people who ask the same dang question every stinking conference call. Let me help you out.
NO THE COVID VARIANTS DON'T MATTER... WE ARE AN IMMUNOMODULATORY DRUG NOT AN ANTIVIRAL...had you done any due diligence before dropping money on this and then watched any Dr been presentation or listened to the last 300 conference calls you would know this..
Almost forgot...I thought their take on potential suitors was interesting and that NP and SK are on their way to see a wealthy individual in los Angeles about a possible trial. Ok I'm done now.
(3)
(0)
